Drug Type mRNA |
Synonyms IN 022, IN022 |
Target |
Mechanism CBS modulators(cystathionine beta-synthase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationRare Pediatric Disease (US), Orphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Homocystinuria | Preclinical | US | 19 Jul 2024 |